Clinical Trials Browser

Unknown × OTHER × dapagliflozin × Clear all

NCT06341842 2024-04-02

PROTECT

Phase 2 Unknown

Breast Neoplasms, Cardiotoxicity

NCT05025735 2021-10-19

Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms